MORGAN STANLEY PLC/CALL/NOVARTIS N/90/0.1/20.12.24 Share Price

Warrant

DE000ME1WH48

Market Closed - Börse Stuttgart 12:22:24 29/06/2024 am IST
0.86 EUR -1.15% Intraday chart for MORGAN STANLEY PLC/CALL/NOVARTIS N/90/0.1/20.12.24
Current month+30.30%
1 month+43.33%
Date Price Change
28/24/28 0.86 -1.15%
27/24/27 0.87 -5.43%
26/24/26 0.92 +3.37%
25/24/25 0.89 0.00%
24/24/24 0.89 +14.10%

Delayed Quote Börse Stuttgart

Last update June 29, 2024 at 12:22 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME1WH4
ISINDE000ME1WH48
Date issued 11/10/2023
Strike 90 CHF
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.93
Lowest since issue 0.29
Delta0.76x
Omega 8.736
Premium2.3x
Gearing11.48x
Moneyness 1.069
Difference Strike -6.17 CHF
Difference Strike %-6.86%
Spread 0.02
Spread %2.27%
Theoretical value 0.8700
Implied Volatility 16.13 %
Total Loss Probability 27.46 %
Intrinsic value 0.6408
Present value 0.2292
Break even 98.38 €
Theta-0.01x
Vega0.02x
Rho0.03x

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.04%
Consensus